• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer

How eClinicalWorks Agentic AI Is Helping Revenue Cycle Leaders Improve Financial Performance
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Fred Pennic, Editor-in Chief | HIT Consultant

Fred Pennic is the Founder and Editor-in-Chief of HIT Consultant.

FDA Grants De Novo Authorization to Avulux, Establishing First Device Classification for Migraine Light Sensitivity

by Fred Pennic 08/25/2026 Leave a Comment

FDA Grants De Novo Authorization to Avulux, Establishing First Device Classification for Migraine Light Sensitivity

What You Should Know The U.S. Food and Drug Administration (FDA) has granted De Novo marketing authorization to Avulux, establishing a first-of-its-kind, FDA-recognized medical device classification for precision optical filters designed to manage migraine-associated light sensitivity.Decreases the impact of light sensitivity in patients diagnosed with episodic migraine aged 12 years and older, serving as an over-the-counter, non-invasive complement to usual care and pharmacological
Read More

Roche Receives FDA Clearance for Elecsys pTau217, First Single-Biomarker Alzheimer’s Blood Test for Primary and Specialty Care

by Fred Pennic 08/24/2026 Leave a Comment

Roche Receives FDA Clearance for Elecsys pTau217, First Single-Biomarker Alzheimer’s Blood Test for Primary and Specialty Care

What You Should Know The U.S. Food and Drug Administration (FDA) has cleared Roche’s Elecsys® Phospho-Tau (217P) Plasma (pTau217) blood test, developed in strategic collaboration with Eli Lilly and Company.It is the first and only FDA-cleared, single-biomarker blood test supporting both rule-in and rule-out assessment of amyloid pathology associated with Alzheimer’s disease using the exact same validated clinical cutoffs across both primary care and specialty neurology settings.The test is
Read More

Arintra Secures $25M to Scale GenAI Autonomous Medical Coding

by Fred Pennic 08/24/2026 Leave a Comment

Arintra Secures $25M to Scale GenAI Autonomous Medical Coding

What You Should Know Arintra, an autonomous medical coding startup headquartered in Austin, Texas, with engineering operations in Bengaluru, raised approximately $25 million in a Series B funding round led by Define Ventures.The syndicate includes new strategic backing from Yale New Haven Ventures and Endeavor Ventures, alongside participation from existing investors Y Combinator, Ten13 Capital, Counterpart Ventures, Spider Capital, and Peak XV Partners (which previously led Arintra’s $21
Read More

UNC Health Rebrands Rex Health Ventures to Launch UNC Health Ventures Strategic Investment Platform

by Fred Pennic 08/21/2026 Leave a Comment

UNC Health Rebrands Rex Health Ventures to Launch UNC Health Ventures Strategic Investment Platform

What You Should Know UNC Health officially announced the rebranding and expansion of Rex Health Ventures into UNC Health Ventures, establishing a unified, systemwide corporate venture capital (CVC) and strategic investment platform.The venture platform builds on more than a decade of strategic healthcare investing, having supported nearly 30 early-stage healthcare companies since its founding in 2012.UNC Health Ventures is directly funded through UNC Health’s broader investment portfolio,
Read More

Cityblock Acquires Homeward and Secures $116M to Unify Urban-Rural Care

by Fred Pennic 08/20/2026 Leave a Comment

Cityblock Acquires Homeward and Secures $116M to Unify Urban-Rural Care

What You Should Know Cityblock Health entered into a definitive agreement to acquire Homeward Health in an all-stock transaction, paired with a $116M Series E financing round led by General Catalyst.The combined entity now serves nearly 200,000 members nationwide across Medicaid, Medicare Advantage, and dual-eligible programs, generating $2.2B in annualized revenue (up 77% year-over-year and more than 4x its 2021 fundraise level).Homeward Health brings a dedicated rural-first Medicare
Read More

Bristol Myers Squibb Partners with Chai Discovery for AI Antibody Design

by Fred Pennic 08/20/2026 Leave a Comment

Chai Discovery Raises $400M to Accelerate AI-Driven Molecular Design Platform

What You Should Know Chai Discovery announced a strategic biopharmaceutical collaboration with Bristol Myers Squibb (BMS) to advance the discovery and engineering of therapeutic antibodies using artificial intelligence.Bristol Myers Squibb will integrate Chai’s proprietary molecular folding and de novo design models across its drug discovery portfolio to power an AI-driven, continuously learning discovery system.Chai Discovery’s platform acts as a computer-aided design (CAD) suite for
Read More

Radial Acquires Mindful Health Solutions MSO to Scale 27-Clinic Brain Medicine Network

by Fred Pennic 08/20/2026 Leave a Comment

Radial Acquires Mindful Health Solutions MSO to Scale 27-Clinic Brain Medicine Network

What You Should Know Radial has acquired the Management Services Organization (MSO) supporting Mindful Health Solutions, creating the nation’s largest clinical management network dedicated to advanced brain medicine and interventional psychiatry.The combined management platform supports 27 outpatient clinics across California, Texas, Washington, and New York, encompassing over 100 clinicians and serving hundreds of thousands of patients with major depressive disorder (MDD), PTSD, OCD, tardive
Read More

XiFin Names Chris Martin Chief Product Officer Amid Rapid AI-Enabled Empower Platform Growth

by Healthcare Executive Hires 08/20/2026 Leave a Comment

XiFin Names Chris Martin Chief Product Officer Amid Rapid AI-Enabled Empower Platform Growth

What You Should Know XiFin, Inc. appointed Chris Martin as Chief Product Officer (CPO) to lead product strategy, drive solution modularity, and expand adoption of the company's AI-enabled XiFin Empower revenue cycle management (RCM) platform.Martin's appointment follows the February 2026 hiring of Chief Technology Officer Sanjay Kumar, forming a technical leadership pairing focused on translating AI innovation into measurable customer value across new healthcare segments.XiFin reported a
Read More

WellSky Unveils AI Summarization and Post-Acute Tracking Across 120,000 Providers

by Fred Pennic 08/20/2026 Leave a Comment

WellSky Launches AI Ambient Listening in Specialty Care EHR to Cut Documentation Time by 41%

What You Should Know WellSky announced two new capabilities within its WellSky CarePort® care transition suite: CareBrief (AI-driven clinical summarization) and Patient Visibility Pro (longitudinal post-discharge tracking).Integrated into WellSky CarePort Transition and Care Management workflows, the tools address clinical data fragmentation and lack of visibility after hospital discharge.CareBrief synthesizes external clinical, social, and post-acute data from outside the hospital EHR into
Read More

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

by Fred Pennic 08/20/2026 Leave a Comment

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

What You Should Know Weave Communications, Inc. entered into a definitive agreement to be acquired by global technology investment firm Francisco Partners in an all-cash take-private transaction valued at an aggregate equity valuation of approximately $650M.Weave stockholders will receive $7.40 per share in cash, representing an approximate 34% premium over the company’s unaffected closing stock price on August 17, 2026.Upon completion of the transaction, expected in the fourth quarter of
Read More

  • Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 16
  • Go to page 17
  • Go to page 18
  • Go to page 19
  • Go to page 20
  • Interim pages omitted …
  • Go to page 572
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

How eClinicalWorks Agentic AI Is Helping Revenue Cycle Leaders Improve Financial Performance

Most-Read

Oura Acquires Counsel Health for $625M: Scaling Continuous Biometrics into On-Demand Medical Care

M&A: Oura Acquires Counsel Health for $625M: Scaling Continuous Biometrics into On-Demand Medical Care

WittKieffer 2026 Healthcare CIO Survey: 82% Sit on Executive Teams, Yet Only 36% Have Formal Succession Plans

WittKieffer 2026 Healthcare CIO Survey: 82% Sit on Executive Teams, Yet Only 36% Have Formal Succession Plans

CVS Rebrands Health Services Segment, Launches Model for Retail Pharmacy Reimbursement

CVS Health Formalizes Tax-Free Split-Off to Carve Out CVS Pharmacy by 2028

SAMHSA and ONC Invest $20M in Behavioral Health IT Initiative

ONC Finalizes HTI-5 Deregulatory Rule to Cut $1.55B in Health IT Compliance and Accelerate FHIR APIs

Redesign Health Merges with Sheba Medical Center’s ARC Global and Agrees to Acquire AVIA

Redesign Health Merges with Sheba Medical Center’s ARC Global and Agrees to Acquire AVIA

Sword Acquires Headspace in All-Cash Deal Worth Up to $300M to Unify Physical and Mental AI Care

M&A: Sword Acquires Headspace in All-Cash Deal Worth Up to $300M to Unify Physical and Mental AI Care

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Redesign Health Study: 71% of Health Systems Adopt an "Epic-First" AI Purchasing Strategy

Redesign Health Study: 71% of Health Systems Adopt an “Epic-First” AI Purchasing Strategy

iRhythm to Acquire VitalConnect for $287.5M to Build Broad Cardiac Intelligence Platform

M&A: iRhythm to Acquire VitalConnect for $287.5M to Build Broad Cardiac Intelligence Platform

Footer

Company

  • About Us
  • 2026 Editorial Calendar
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2026. HIT Consultant Media. All Rights Reserved. Privacy Policy |